Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

Incanthera appoints Laura Brogden as CFO

She joins from Summ.it

- PMLiVE

PharmaLex strengthens international team

Consultancy group appoints Adrian Pencak

National Institute for Health and Care Excellence NICE logo

NICE backs GSK’s ‘bubble baby’ gene therapy

Strimvelis will treat children under the NHS for immunodeficiency

- PMLiVE

Meetings

Ensuring a box office success

- PMLiVE

GSK’s shingles vaccine Shingrix claims US approval

Becomes first alternative to Merck & Co’s Zostavax

Janssen’s quest to prevent diseases taking hold

Johan van Hoof, general manager of Janssen Vaccines & Prevention, on 'recalibrating' public understanding of illness

- PMLiVE

Janssen’s quest to prevent diseases taking hold

Johan van Hoof, general manager of Janssen Vaccines & Prevention, on 'recalibrating' public understanding of illness

Over two thirds of UK residents don’t believe that the state will be able to provide for their healthcare needs in later life

One of the findings of a new report by Health Unlimited and Foresight Factory.

Health Unlimited

- PMLiVE

The Power of Storytelling in Health: Friend or Foe?

With traditional media moving online, and the era of social media driving stories through the ethernet, never has a ‘story’ been more impactful.

- PMLiVE

Kite wins FDA approval for blood cancer drug Yescarta

Becomes the first CAR-T therapy approved in the US for B-cell lymphoma

- PMLiVE

Tools for the digital world

The next step for the pharma industry

Gilead Sciences promotes Dr Alessandro Riva to EVP, oncology therapeutics

He's been with the firm since January, when he joined from Novartis

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links